IXICO Plc (IXI)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:IXICO Plc (IXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014377
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints. The company provides clinical trial services for assessing the safety and efficacy of drugs. Its product portfolio includes web-based platform to transfer data; web-based system to track imaging-based research study or clinical trial in real time; medical device for clinical diagnosis of dementia; and others. IXICO’s mehealth is secure online software for clinicians at the point-of-care to support patient-centered, evidence-based decision making and improve the monitoring and treatment of patients. The company also has its operational presence in the US and the UK. IXICO is headquartered in London, the UK.

IXICO Plc (IXI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IXICO Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IXICO Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IXICO Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IXICO Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
IXICO Plc, Medical Devices Deals, 2011 to YTD 2017 9
IXICO Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
IXICO Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
IXICO Enters into Partnership with Pharmaceutical Company 11
Licensing Agreements 12
VirtualScopics Enters into Licensing Agreement with Ixico 12
Equity Offering 13
Ixico Plans to Raise USD2.7 Million in Private Placement of Shares 13
Acquisition 15
Ixico Acquires Optimal Medicine for USD2.3 Million 15
Phytopharm Acquires IXICO for USD8.5 Million in Reverse Takeover Transaction 16
IXICO Plc – Key Competitors 17
IXICO Plc – Key Employees 18
IXICO Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
May 22, 2017: IXICO: Half Yearly Report to 31 March 2017 20
Jun 07, 2016: IXICO Announces Half Yearly Report to 31 March 2016 21
Jan 07, 2016: IXICO’s Financial Results for 2015 22
Corporate Communications 23
Jan 17, 2017: IXICO appoints Giulio Cerroni as Chief Executive Officer 23
Sep 16, 2016: IXICO: Board Changes 24
Jan 22, 2016: IXICO selected to participate in two NHS Innovation Test Beds 25
Government and Public Interest 26
Mar 09, 2016: European research to tackle the triple challenge of dementia, hearing and vision impairment 26
Mar 09, 2016: IXICO to Participate in SENSE-Cog, a Pan European Consortium 27
Product News 28
Aug 23, 2016: IXICO and Cambridge Cluster Study to Detect Early Signs of Alzheimer’s Disease 28
Other Significant Developments 29
Jul 18, 2017: IXICO hosts Alzheimer Expert Symposium 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
IXICO Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
IXICO Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IXICO Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IXICO Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IXICO Plc, Deals By Therapy Area, 2011 to YTD 2017 8
IXICO Plc, Medical Devices Deals, 2011 to YTD 2017 9
IXICO Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
IXICO Enters into Partnership with Pharmaceutical Company 11
VirtualScopics Enters into Licensing Agreement with Ixico 12
Ixico Plans to Raise USD2.7 Million in Private Placement of Shares 13
Ixico Acquires Optimal Medicine for USD2.3 Million 15
Phytopharm Acquires IXICO for USD8.5 Million in Reverse Takeover Transaction 16
IXICO Plc, Key Competitors 17
IXICO Plc, Key Employees 18
IXICO Plc, Subsidiaries 19

★海外企業調査レポート[IXICO Plc (IXI)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Askari General Insurance Co. Ltd:企業の戦略・SWOT・財務情報
    Askari General Insurance Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Askari General Insurance Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • OncoSec Medical Inc (ONCS):医療機器:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • CSL Ltd (CSL):医療機器:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Simpson Manufacturing Co Inc (SSD):企業の財務・戦略的SWOT分析
    Simpson Manufacturing Co Inc (SSD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Willis Lease Finance Corporation (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corporation (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Micell Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • POSCO:企業の戦略・SWOT・財務情報
    POSCO - Strategy, SWOT and Corporate Finance Report Summary POSCO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, …
  • AGL Energy Ltd (AGL):石油・ガス:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Toppan Printing Co Ltd:企業の戦略・SWOT・財務情報
    Toppan Printing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Printing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Timken Co (TKR):電力:M&Aディール及び事業提携情報
    Summary The Timken Co (Timken) is an industrial technology company that develops, produces and sells mechanical components. The company offers engineered bearings, mechanical power transmission products, switch gears and electric motors and generators. Timken also offers remanufacture and repair, ma …
  • Balaji Amines Ltd (BALAMINES):企業の財務・戦略的SWOT分析
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • AbbVie Inc.:企業の戦略・SWOT・財務情報
    AbbVie Inc. - Strategy, SWOT and Corporate Finance Report Summary AbbVie Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Haemonetics Corp (HAE):企業の製品パイプライン分析2018
    Summary Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. Its portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite o …
  • Intec Pharma Ltd (NTEC):製薬・医療:M&Aディール及び事業提携情報
    Summary Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solutio …
  • Murmanskoye Morskoye Parokhodstvo:企業の戦略・SWOT・財務分析
    Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report Summary Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sysmex Inostics GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Inostics GmbH (Sysmex Inostics), formerly Inostics GmbH, a subsidiary of Sysmex Corp, is a molecular diagnostics company that offers blood-based cell-free tumor treatment solutions. The company offers services such as clinical trials, research and development, and testing for physicia …
  • Imperial Oil Ltd (IMO):石油・ガス:M&Aディール及び事業提携情報
    Summary Imperial Oil Ltd (Imperial Oil), a subsidiary of Exxon Mobil Corporation, is an integrated energy company. It is present across the value chain in petroleum industry including the exploration, production and sale of crude oil and natural gas. The company explores for and produces crude oil, …
  • The Magstim Co Ltd:企業の戦略的SWOT分析
    The Magstim Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Nippon Paper Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆